Draquinolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K3B3L3Q0GV. European Medicines Agency schedules Draquinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06397MIG. Draquinolol generally arises in the molecular formula C24H30N2O4. The term DRAQUINOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26.) DRAQUINOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule draquinolol under HS 29337900 and SITC 51561. As of Q4 2014, DRAQUINOLOL remains the US FDA Preferred Term for this commodity. Draquinolol bears US NLM identifiers UMLS ID C1880408 and NCI Concept Code C65479. SMILES: O(CC(O)CNCCCC)c1ccc(c2n(c(=O)c3c(c2)ccc(OC)c3)C)cc1.